Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01269853 : Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
PhasePhase 1/Phase 2
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

- 18 years of age or older.

- Patients with a documented histologic diagnosis of relapsed or refractory glioblastoma
multiforme (GBM), anaplastic astrocytoma (AA) or anaplastic mixed oligoastrocytoma
(AOA).

- Patients must have at least one confirmed and evaluable tumor site. A confirmed tumor
site is one in which is biopsy-proven.

- Patients must have a Karnofsky performance status 70% (or the equivalent ECOG level of
0-2).

- Patients must agree to use a medically effective method of contraception during and
for a period of three months after the treatment period.

Exclusion Criteria:

- Previous treatment with greater than 2 cycles of Bevacizumab at 10mg/kg (2 IV
Infusions).

- Women who are pregnant or lactating.

- Patients with significant inter-current medical or psychiatric conditions that would
place them at increased risk or affect their ability to receive or comply with
treatment or post-treatment clinical monitoring.
LinksPermanent Link to THIS page: http://virtualtrials.com/nct/display1trial.cfm?nct=NCT01269853      |      Link to official Clinicaltrials.gov listing
Locations
New York, New York
Facility: Lenox Hill Brain Tumor Center
Investigator: John Boockvar, MD
Contact: John Boockvar, MD Phone: 212-434-3905
Click HERE to send email to this center




Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites